3/14/2013

Nanosphere has received CE mark approval to market its Gram-Negative Blood Culture, or BC-GN, test in Europe. The device, which runs on the company's automated Verigene System, allows for the rapid diagnosis of bacteria that can trigger bloodstream infections.

Full Story:
RTT News

Related Summaries